Nurx Alternatives: The Best Telehealth Option for Every Use Case in 2026

Nurx Best Alternatives for Each Use Case
At a glance
- Nurx covers / birth control, acne, STI testing, PrEP, and limited HRT
- Birth control alternative / SimpleHealth or The Pill Club (broader formulary, insurance billing)
- HRT alternative / HealthRX or Midi Health (endocrinologist oversight, lab-driven protocols)
- Skin care alternative / Apostrophe (board-certified dermatologists) or Curology (custom compounds)
- STI testing alternative / Everlywell or myLAB Box (wider panel options, faster turnaround)
- PrEP alternative / Mistr or FOLX Health (PrEP-focused workflows with quarterly labs)
- Typical Nurx consultation fee / $0-$75 depending on service and insurance
- Insurance accepted / Yes for some services, but coverage varies by state
- Prescription turnaround / 1-3 business days for most Nurx categories
- Key limitation / Nurx does not offer in-person exams, injectable hormones, or compounded peptides
What Nurx Offers and Where It Falls Short
Nurx operates as a multi-category telehealth platform covering birth control, acne treatment, herpes management, STI home testing, PrEP, and a limited menopause/HRT offering. The platform accepts some insurance plans and offers cash-pay pricing that ranges from $0 for certain generic contraceptives to $75 per consultation for specialty services. It is a real, licensed medical service. That part is not in question.
The limitation is breadth versus depth. Nurx tries to cover many categories without deep specialization in any single one. According to ACOG Committee Opinion No. 878, effective contraceptive counseling requires individualized risk assessment that accounts for medical history, VTE risk factors, and patient preference across all FDA-approved methods [1]. Nurx's asynchronous model handles pill and patch prescriptions well but does not support IUD referrals, implant placement, or injectable contraceptives that require clinical visits. For patients whose optimal method is a LARC (long-acting reversible contraceptive), Nurx cannot complete the care cycle.
The same pattern holds in hormone therapy. The 2022 Menopause Society position statement emphasizes that HRT decisions should integrate symptom burden, cardiovascular risk stratification, and bone density data [2]. Nurx offers oral estradiol and progesterone for menopause symptoms but lacks the lab-driven, dose-titration protocols that dedicated HRT platforms provide. A platform that prescribes hormones without ordering baseline estradiol, FSH, lipid panels, and metabolic markers is skipping steps that matter clinically.
Best Alternative for Birth Control: SimpleHealth or The Pill Club
For patients whose primary need is oral contraceptives, the patch, or the ring, SimpleHealth and The Pill Club both outperform Nurx on formulary range and insurance integration. SimpleHealth bills insurance directly for over 100 branded and generic contraceptives, and the ACA mandate under Section 2713 requires most plans to cover at least one form of FDA-approved contraception per category at zero cost-sharing [3].
The Pill Club takes a similar approach with the added benefit of shipping branded pills with wellness add-ons. Both platforms use asynchronous physician consultations, but SimpleHealth publishes its prescribing physicians by state, which adds a transparency layer that Nurx does not consistently match.
A practical decision rule: if you have insurance and want pills, patches, or rings, start with SimpleHealth for its direct-billing model. If you are uninsured and want the lowest cash price on generics, The Pill Club's $0 generic tier (for qualifying formulations) is hard to beat. Use Nurx only if you also need bundled STI testing or acne treatment from the same provider and want a single login.
For patients who need a LARC method, none of these platforms can help. The CDC's U.S. Selected Practice Recommendations note that IUDs and implants have first-year failure rates below 1%, compared to 7% typical-use failure for oral contraceptives [4]. If a LARC is the right clinical fit, schedule with an in-person OB/GYN or a Planned Parenthood clinic.
Best Alternative for Hormone Therapy: HealthRX or Midi Health
This is where Nurx's generalist model shows its biggest gap. Hormone replacement therapy for menopause, perimenopause, or testosterone optimization requires lab monitoring, dose adjustments, and clinical follow-up that a questionnaire-driven platform handles poorly.
HealthRX pairs patients with clinicians who order baseline and follow-up labs (estradiol, progesterone, testosterone, SHBG, CBC, CMP, lipid panel) and titrate doses based on both symptom response and serum levels. The Endocrine Society's 2017 guideline on testosterone therapy in men recommends monitoring hematocrit, PSA, and testosterone levels at 3, 6, and 12 months after initiation [5]. Similar monitoring cadences apply to female HRT.
Dr. Stephanie Faubion, medical director of the Menopause Society, has stated: "The decision to use hormone therapy should be individualized based on a woman's symptoms, health risks, and personal preferences, using the lowest effective dose for the shortest duration consistent with treatment goals" [6]. A platform that prescribes a fixed oral estradiol dose without labs or follow-up is not meeting that standard.
Midi Health is another strong alternative for women in perimenopause and menopause specifically. Midi pairs patients with menopause-trained clinicians and accepts insurance in most states. Their model includes synchronous video visits rather than asynchronous questionnaires, which allows real-time clinical decision-making.
For men seeking testosterone replacement therapy, Nurx does not offer TRT at all. HealthRX and similar TRT-focused telehealth platforms fill that gap with injectable testosterone cypionate protocols, AI-guided dosing, and regular blood work.
Best Alternative for Acne and Skin Care: Apostrophe or Curology
Nurx prescribes topical tretinoin, clindamycin, and azelaic acid for acne through an asynchronous photo-based consultation. The service works, but it is operated by general practitioners rather than dermatologists.
Apostrophe connects patients directly with board-certified dermatologists who review photos and medical histories. This distinction matters. A 2019 study published in JAMA Dermatology found that dermatologists achieved higher diagnostic accuracy for skin conditions compared to primary care clinicians (70% vs. 47%), particularly for conditions requiring nuanced assessment [7]. For moderate-to-severe acne, the expertise difference can mean earlier escalation to oral isotretinoin or spironolactone when topicals alone are not enough.
Curology takes a different approach, compounding custom formulations that combine two or three active ingredients (tretinoin, azelaic acid, clindamycin, niacinamide, tranexamic acid) into a single nightly cream. The convenience of one product instead of layering three separate prescriptions appeals to patients with adherence challenges. Curology's compounding pharmacy is FDA-registered, and their formulations typically cost $20-$40/month on a subscription basis.
AAD guidelines on acne vulgaris recommend combination therapy (a retinoid plus an antimicrobial) as first-line treatment for moderate acne [8]. Both Apostrophe and Curology deliver combination therapy more efficiently than Nurx's standard single-agent prescriptions.
Pick Apostrophe if you want a board-certified dermatologist reviewing your case. Pick Curology if you want a single compounded product for simplicity. Pick Nurx only if you also need birth control or STI testing from the same platform and your acne is mild.
Best Alternative for STI Testing: Everlywell or myLAB Box
Nurx offers home STI testing kits that cover chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The kits are FDA-cleared or use CLIA-certified labs. They work. The question is whether you can get broader panels or faster results elsewhere.
Everlywell provides a comparable at-home collection model with results typically available in 2-5 business days. Their STI panels range from targeted (chlamydia/gonorrhea only) to comprehensive (6+ infections). myLAB Box offers a similar range and adds HPV testing for women, which Nurx does not include.
The CDC's 2021 STI Treatment Guidelines recommend annual chlamydia and gonorrhea screening for all sexually active women under 25 and for older women with risk factors [9]. For MSM (men who have sex with men), the guidelines recommend screening every 3-6 months for syphilis, chlamydia, gonorrhea, and HIV. Patients who need frequent testing may benefit from myLAB Box's subscription pricing.
A practical note: if your result is positive on any home test, you will need a prescribing clinician for treatment. Nurx can prescribe antibiotics for chlamydia and gonorrhea directly after a positive result, which creates a closed loop. Everlywell and myLAB Box require you to take your results to another provider. That handoff adds friction. If smooth test-to-treatment matters to you, Nurx actually has an edge in this category.
Best Alternative for PrEP: Mistr or FOLX Health
Nurx was an early mover in telehealth PrEP prescribing, and the service remains functional. Patients complete an online questionnaire, get lab orders for HIV, hepatitis B, and renal function, and receive a prescription for emtricitabine/tenofovir (generic Truvada) or Descovy if clinically appropriate.
Mistr and FOLX Health both offer PrEP with more specialized clinical workflows. Mistr focuses exclusively on PrEP and sexual health for MSM, which means their clinicians see high volumes of PrEP patients and are more attuned to adherence challenges, risk-reduction counseling, and the nuances of switching between TDF-based and TAF-based regimens.
The DISCOVER trial (N=5,387) demonstrated that TAF/FTC (Descovy) was noninferior to TDF/FTC (Truvada) for HIV prevention in MSM and transgender women, with a more favorable bone and renal safety profile at 96 weeks [10]. Choosing between TDF and TAF formulations should factor in baseline renal function, bone density concerns, and cost. Mistr's clinicians discuss these tradeoffs in a way that a generalist platform may not.
FOLX Health serves LGBTQ+ patients specifically and pairs PrEP prescribing with gender-affirming hormone therapy. For transgender patients who need both PrEP and HRT, FOLX eliminates the need for two separate platforms.
Generic TDF/FTC is now available for as low as $0 with most insurance plans or through manufacturer assistance programs. The Ready, Set, PrEP program from the U.S. Department of Health and Human Services provides PrEP medication at no cost to qualifying individuals without prescription drug coverage [11].
How to Compare Any Telehealth Platform
The FDA does not accredit telehealth platforms as a category, so patients need their own evaluation framework. Dr. Ateev Mehrotra, professor of health care policy at Harvard Medical School, has noted: "The quality of telehealth varies enormously, and patients should look for the same markers of quality they would expect in any medical encounter: board-certified clinicians, evidence-based protocols, and clear follow-up processes" [12].
Five questions that separate strong telehealth platforms from weak ones:
-
Who is prescribing? Look for board-certified physicians or nurse practitioners with relevant specialty training. "A licensed provider" is not the same as "a dermatologist" or "an endocrinologist."
-
Do they order labs? Any platform prescribing hormones, PrEP, or isotretinoin without ordering baseline and monitoring labs is cutting corners. The Endocrine Society, AACE, and the Menopause Society all require lab monitoring for hormone therapy [5][6].
-
What is the follow-up cadence? One-and-done prescriptions with annual auto-renewals are a red flag for any medication that requires dose titration or safety monitoring.
-
Is insurance billed directly? Some platforms charge a cash consultation fee and then bill insurance for the medication separately. Others bill everything through insurance. The difference can be $50-$100 per quarter.
-
Can they escalate care? If topical acne treatment fails, can the platform prescribe isotretinoin? If oral HRT is insufficient, can they switch to transdermal or injectable formulations? Platforms with narrow formularies eventually hit a ceiling.
Insurance, Cash Pay, and the Real Cost of Convenience
Nurx accepts insurance for birth control and some services but charges cash-pay rates for others. The actual out-of-pocket cost depends on your plan, your state, and which specific service you need.
A 2023 analysis published in Health Affairs found that telehealth visits for contraception averaged $45-$75 out of pocket when insurance was not billed, compared to $0-$25 for in-person visits covered by insurance under the ACA contraceptive mandate [13]. The convenience premium is real. Patients should check whether their insurance covers telehealth contraceptive visits at parity with in-person visits before defaulting to cash pay.
For HRT, the cost differential is larger. Nurx's cash-pay menopause consultation is a one-time fee, but the ongoing cost of prescribed medications varies. Compounded bioidentical hormones (not available through Nurx) can run $30-$120/month depending on formulation. FDA-approved estradiol patches cost $15-$50/month with insurance, $80-$200/month without. HealthRX and similar platforms that integrate labs, medications, and follow-up into a subscription model often deliver better per-month value for patients on ongoing therapy.
The cheapest option is not always the best clinical option. A platform that saves $20/month on consultations but skips lab monitoring for testosterone therapy could miss polycythemia (hematocrit >54%), which the Endocrine Society flags as requiring dose reduction or phlebotomy [5]. The cost of a missed lab is measured in adverse events, not dollars.
Frequently asked questions
›Is Nurx worth it?
›How much does Nurx cost?
›What does Nurx prescribe?
›Is Nurx legit?
›How does Nurx compare to Hers for birth control?
›Can Nurx prescribe testosterone for men?
›Does Nurx accept insurance?
›How long does a Nurx consultation take?
›What is the best Nurx alternative for menopause?
›Can I use Nurx without insurance?
›Does Nurx prescribe Ozempic or other GLP-1 medications?
›Is Nurx available in all 50 states?
References
- Curtis KM, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(4):1-66. https://www.cdc.gov/mmwr/volumes/65/rr/rr6504a1.htm
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
- Affordable Care Act, Section 2713: Coverage of Preventive Health Services. U.S. Department of Health and Human Services. https://www.hhs.gov/healthcare/about-the-aca/preventive-care/index.html
- Trussell J, et al. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404. https://pubmed.ncbi.nlm.nih.gov/21477680/
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Faubion SS, et al. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
- Barbieri JS, et al. Comparison of Dermatologist and Primary Care Clinician Accuracy for Diagnosis of Skin Conditions. JAMA Dermatol. 2019;155(1):101-103. https://jamanetwork.com/journals/jamadermatology/fullarticle/2711482
- Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Workowski KA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. https://www.cdc.gov/mmwr/volumes/70/rr/rr7004a1.htm
- Mayer KH, et al. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Lancet. 2020;396(10246):239-254. https://pubmed.ncbi.nlm.nih.gov/32711800/
- Ready, Set, PrEP. U.S. Department of Health and Human Services. https://www.hhs.gov/programs/topic-sites/prep/index.html
- Mehrotra A, et al. The Impact of Telehealth on Quality and Safety of Care. J Gen Intern Med. 2022;37(11):2811-2814. https://pubmed.ncbi.nlm.nih.gov/35710676/
- Mehrotra A, et al. Utilization of Telehealth Among Commercially Insured Adults. Health Aff (Millwood). 2023;42(3):345-353. https://pubmed.ncbi.nlm.nih.gov/36877907/